Adjunct to conventional therapies: Because mechanisms differ from finasteride (systemic 5-AR type 2 inhibition) and minoxidil (K_ATP channel opening/vasodilation), GHK-Cu could be paired with these or with low-level light therapy, microneedling, or PRP to address inflammation, ECM health, and microvascular support key complements for comprehensive regrowth regimens
The organization also warns that since its not approved for human clinical use by any global regulatory authority, it may lead to negative health effects including immunogenic reactions (antibodies), peptide impurities, and limited safety data for proposed routes of use
Some patients have described feelings of fatigue, body aches, or a sense of mental haze before they start noticing the improvements
See the full ICD-10 and J-code pairing table in the reference section above for all 24 drug mappings with diagnosis codes and prior authorization status